Simble Solutions Limited announced that Dr. Daniel Tillett has joined the Board of Directors in order to provide additional direction and leadership to the Company through its next stage of evolution. Dr. Tillett is the founder and CEO of Nucleics. He is also Executive Director and Chief Scientific Officer of Race Oncology.

Dr. Tillett's appointment is effective immediately.